Skip to main content

Table 4 Competing risk model of clinical outcomes

From: Association of haemoglobin glycation index with outcomes in patients with acute coronary syndrome: results from an observational cohort study in China

 

Unadjusted HR (95% CI)

p value

Adjusted HR

(95% CI)

p value

CV death

 Q5

Ref.

 

Ref.

 

 Q4

0.703 (0.530, 0.931)

0.014

0.655( 0.486, 0.881)

0.005

 Q3

0.547 (0.403, 0.742)

 < 0.001

0.606 (0.438, 0.838)

0.002

 Q2

0.466 (0.340, 0.640)

 < 0.001

0.585 (0.422, 0.811)

0.001

 Q1

0.792 (0.605, 1.037)

0.089

0.811 (0.605, 1.087)

0.160

Non-fatal MI

 Q5

Ref.

 

Ref.

 

 Q4

0.736 (0.551, 0.983)

0.038

0.788 (0.587, 1.057)

0.112

 Q3

0.689 (0.513, 0.924)

0.013

0.806 (0.599, 1.087)

0.157

 Q2

0.732 (0.549, 0.975)

0.033

0.851 (0.636, 1.139)

0.278

 Q1

0.746 (0.560, 0.993)

0.045

0.772 (0.576, 1.036)

0.084

Cardiac rehospitalization

 Q5

Ref.

 

Ref.

 

 Q4

0.895 (0.792, 1.010)

0.072

0.942 (0.833, 1.064)

0.336

 Q3

0.868 (0.768, 0.980)

0.023

0.949 (0.839, 1.074)

0.411

 Q2

0.823 (0.729, 0.931)

0.002

0.894 (0.791, 1.012)

0.077

 Q1

0.892 (0.791, 1.007)

0.065

0.955 (0.843, 1.081)

0.462

Revascularization

 Q5

Ref.

 

Ref.

 

 Q4

0.808 (0.647, 1.008)

0.059

0.907 (0.725, 1.135)

0.393

 Q3

0.747 (0.596, 0.936)

0.011

0.890 (0.709, 1.117)

0.314

 Q2

0.761 (0.609, 0.950)

0.016

0.854 (0.682, 1.069)

0.168

 Q1

0.712 (0.568, 0.893)

0.003

0.746 (0.591, 0.941)

0.013

Non-fatal stroke

 Q5

Ref.

 

Ref.

 

 Q4

0.833 (0.532, 1.305)

0.425

0.924 (0.587, 1.455)

0.734

 Q3

0.512 (0.305, 0.860)

0.011

0.594 (0.350, 1.007)

0.053

 Q2

0.625 (0.387, 1.011)

0.055

0.713 (0.438, 1.160)

0.173

 Q1

0.709 (0.447, 1.126)

0.145

0.762 (0.479, 1.214)

0.253

Non-fatal MACCEs

 Q5

Ref.

 

Ref.

 

 Q4

0.885 (0.790, 0.992)

0.037

0.930 (0.829, 1.044)

0.219

 Q3

0.821 (0.731, 0.923)

0.001

0.904 (0.803, 1.017)

0.093

 Q2

0.794 (0.707, 0.892)

 < 0.001

0.875( 0.779, 0.984)

0.026

 Q1

0.890 (0.794,0.997)

0.044

0.946 (0.842, 1.062)

0.346

  1. CV cardiovascular, MI myocardial infarction, MACCEs Major Adverse Cardiac and Cerebrovascular events